Found 103 matching trials
A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With Hyperphosphatemia PHASE3 This is a phase III multi-centre study in three periods: the first period i...
Show More Location
Multiple Locations
Learn More & Join Trial
Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease EARLY_PHASE1 Fibroblast Growth Factor 23 (FGF23) is a molecule that has been implicated ...
Show More Location
Penn State Milton S. Hershey Medical Center
Learn More & Join Trial
Development of a 'Phosphate Counting Program' NA Hypothesis: The use of a program that assists with selection of the appropr...
Show More Learn More & Join Trial
Effect of the Consumption of Ferric Hydroxide Adipate on Urinary Phosphorus Excretion. EARLY_PHASE1 Ferric hydroxide adipate is a ferric iron supplement containing iron hydrox...
Show More Location
MRC Human Nutrition Research
Learn More & Join Trial
A Study to Investigate the Safety and Efficacy of PA21 (Velphoro®) and Calcium Acetate (Phoslyra®) in Paediatric and Adolescent Chronic Kidney Disease (CKD) Patients With Hyperphosphataemia PHASE3 This is a Phase 3, Open-label, Randomised, Active-controlled, Parallel Grou...
Show More Location
University of Alabama at Birmingham School of Medicine
Learn More & Join Trial
Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis PHASE2 The purpose of this clinical study is to compare the effects of Genz-644470...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients PHASE3 This is a Phase 3, randomised, active controlled, multicentre extension stu...
Show More Location
Multiple Locations
Learn More & Join Trial
Low Phosphate Diets in Patients With Early Stages of Chronic Kidney Disease NA The purpose of this study is to learn more about how the kidneys control th...
Show More Location
Massachusetts General Hospital
Learn More & Join Trial
Efficacy and Safety of Cinacalcet in Pediatric Patients With Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) on Dialysis PHASE3 The primary objective was to evaluate the efficacy of cinacalcet for reduci...
Show More Learn More & Join Trial
Phosphate Binder-combination Study of KHK7791 in Hyperphosphatemia Patients PHASE2 To evaluate the effect and safety of KHK7791 in combination with phosphate ...
Show More Learn More & Join Trial